logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

I-Mab Starts China Trial of In-licensed Interleukin for Solid Tumors

Mar 5, 2019

Life Science

China Finalizes IPO Listing Rules for Shanghai High-Tech Board

Mar 5, 2019

Life Science

SOL Global Announces Formation of International Hemp Company Heavenly Rx,SOL Global宣布成立国际大麻公司Heavenly Rx

SOL Global Announces Formation of International Hemp Company Heavenly Rx

Mar 5, 2019

Cannabis, Life Science

ATLATL Innovation Cluster: An Evolved Kendall Square Miniature in China

Mar 5, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel CEO Provides 2019 Shareholder Update

Mar 5, 2019

Life Science

Lilly to launch a half-price version of insulin

Mar 4, 2019

Life Science

3SBio Will Pay $50 Million Upfront for China Rights to Two TLC Products

Mar 4, 2019

Life Science

WuXi Biologics Signs $220 Million Bi-Specific Deal with ABL Bio of South Korea

Mar 4, 2019

Life Science

Sunniva Inc (CSE:SNN) Cannabis

Sunniva Announces Closing of Second Tranche of Convertible Debt Financing for Gross Proceeds of $3.3 Million

Mar 4, 2019

Life Science

Aslan Out-Licenses Korean Rights for Oncology Drug in $13 Million Deal

Mar 1, 2019

Life Science

China Strengthens Clinical Trial Approval Rules for Cell and Gene Therapies

Mar 1, 2019

Life Science

Cutting in on an Entegris Deal, Merck KGaA Makes $5.9 Billion Bid for Versum

Feb 28, 2019

Life Science

Nanjing’s NJCTTQ Signs $4 Billion In-Licensing Deal for Bi-Specific Immunotherapies from Abpro

Feb 28, 2019

Life Science

Titan Medical Expands Global Intellectual Property Portfolio to 30 Patents Issued and 75 Pending with Receipt of First Patent in China

Feb 28, 2019

Life Science

WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA,药明生物合作伙伴Amicus新一代疗法获FDA突破性疗法认定

WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

Feb 28, 2019

Life Science

Beijing Surgerii Completes A Round for Next-Gen Robotic Surgery Device

Feb 27, 2019

Life Science

Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics

Feb 26, 2019

Life Science

CStone Pharma Completes $285 Million Hong Kong IPO; Trades Higher

Feb 26, 2019

Life Science

  • ‹‹ Previous
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada